Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Maravai Lifesciences Holdings (MRVI) Asset Utilization Ratio (2021 - 2025)

Maravai Lifesciences Holdings has reported Asset Utilization Ratio over the past 5 years, most recently at 0.23 for Q4 2025.

  • Quarterly results put Asset Utilization Ratio at 0.23 for Q4 2025, up 1.16% from a year ago — trailing twelve months through Dec 2025 was 0.23 (up 1.16% YoY), and the annual figure for FY2025 was 0.21, up 0.55%.
  • Asset Utilization Ratio for Q4 2025 was 0.23 at Maravai Lifesciences Holdings, up from 0.22 in the prior quarter.
  • Over the last five years, Asset Utilization Ratio for MRVI hit a ceiling of 0.45 in Q1 2022 and a floor of 0.15 in Q4 2023.
  • Median Asset Utilization Ratio over the past 5 years was 0.24 (2023), compared with a mean of 0.29.
  • Biggest five-year swings in Asset Utilization Ratio: skyrocketed 55.43% in 2022 and later tumbled 60.51% in 2023.
  • Maravai Lifesciences Holdings' Asset Utilization Ratio stood at 0.42 in 2021, then fell by 7.03% to 0.39 in 2022, then tumbled by 60.51% to 0.15 in 2023, then surged by 47.31% to 0.23 in 2024, then increased by 1.16% to 0.23 in 2025.
  • The last three reported values for Asset Utilization Ratio were 0.23 (Q4 2025), 0.22 (Q3 2025), and 0.24 (Q2 2025) per Business Quant data.